Orange Book product · Brand (NDA)
SUPRENZA
PHENTERMINE HYDROCHLORIDE
At a glance
Jun 13, 2011
Approved
Brand (NDA)
Application
Not listed
TE code
1
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Jun 13, 2011
15 yr 3 mo ago
Today
Patent 8440170 expires
Listed drug product patent expiration.
Mar 14, 2029
in 2 yr 9 mo
Pharmaceutical detail
Active ingredient
PHENTERMINE HYDROCHLORIDE
Strength
15MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Dosage form
TABLET, ORALLY DISINTEGRATING
Route
ORAL
TE code
Not listed
Application
NDA 202088
Product number
001
Marketing status
DISCN
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyThis is a brand (NDA) product. Other products sharing this active ingredient are listed below.
- —FASTINBrand (NDA)
NDA 017352 · GLAXOSMITHKLINE
- 2016PHENTERMINE HYDROCHLORIDEGeneric (ANDA)
ANDA 204318 · AUROLIFE PHARMA LLC
- 2014PHENTERMINE HYDROCHLORIDEGeneric (ANDA)
ANDA 205019 · NUVO PHARM
- 2014PHENTERMINE HYDROCHLORIDEGeneric (ANDA)
ANDA 205017 · NUVO PHARM
- 2014PHENTERMINE HYDROCHLORIDEGeneric (ANDA)
ANDA 204414 · INVAGEN PHARMS
- 2014PHENTERMINE HYDROCHLORIDEGeneric (ANDA)
ANDA 202858 · INVAGEN PHARMS
- 2014PHENTERMINE HYDROCHLORIDEGeneric (ANDA)
ANDA 202846 · INVAGEN PHARMS
- 2012PHENTERMINE HYDROCHLORIDEGeneric (ANDA)
ANDA 202248 · ELITE LABS
- 2012PHENTERMINE HYDROCHLORIDEGeneric (ANDA)
ANDA 087022 · LANNETT
- 2011PHENTERMINE HYDROCHLORIDEGeneric (ANDA)
ANDA 201961 · LANNETT CO INC
- 2010PHENTERMINE HYDROCHLORIDEGeneric (ANDA)
ANDA 091359 · LANNETT CO INC
- 2010PHENTERMINE HYDROCHLORIDEGeneric (ANDA)
ANDA 090591 · BARR
Listed patents (1)
| Patent | Expires | In | Type |
|---|---|---|---|
| 8440170 | Mar 14, 2029 | in 2 yr 9 mo | Product |

